Zuo Q, Kang Y
Adv Exp Med Biol. 2025; 1464():347-370.
PMID: 39821033
DOI: 10.1007/978-3-031-70875-6_17.
Chong Z, Huang F, McLeod M, Irwin R, Smithson M, Yue Z
Res Sq. 2024; .
PMID: 39011117
PMC: 11247942.
DOI: 10.21203/rs.3.rs-4456000/v1.
Ramos C, Gerakopoulos V, Oehler R
Br J Cancer. 2024; 131(3):407-419.
PMID: 38783165
PMC: 11300623.
DOI: 10.1038/s41416-024-02717-4.
Advani D, Kumar P
Mol Neurobiol. 2024; 61(11):8600-8630.
PMID: 38532240
DOI: 10.1007/s12035-024-04130-7.
Rakhmatullina A, Mingaleeva R, Gafurbaeva D, Glazunova O, Sagdeeva A, Bulatov E
J Pers Med. 2023; 13(11).
PMID: 38003936
PMC: 10672200.
DOI: 10.3390/jpm13111621.
Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer.
Serebriiskii I, Pavlov V, Andrianov G, Litwin S, Basickes S, Newberg J
NPJ Genom Med. 2023; 8(1):40.
PMID: 38001126
PMC: 10674024.
DOI: 10.1038/s41525-023-00384-7.
Synthetic lethal approaches to target cancers with loss of PTEN function.
Ertay A, Ewing R, Wang Y
Genes Dis. 2023; 10(6):2511-2527.
PMID: 37533462
PMC: 7614861.
DOI: 10.1016/j.gendis.2022.12.015.
Cancer-associated fibroblasts in gynecological malignancies: are they really allies of the enemy?.
Villegas-Pineda J, Ramirez-de-Arellano A, Bueno-Urquiza L, Lizarazo-Taborda M, Pereira-Suarez A
Front Oncol. 2023; 13:1106757.
PMID: 37168385
PMC: 10164963.
DOI: 10.3389/fonc.2023.1106757.
Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance.
Butti R, Khaladkar A, Bhardwaj P, Prakasam G
Cancer Drug Resist. 2023; 6(1):182-204.
PMID: 37065872
PMC: 10099601.
DOI: 10.20517/cdr.2022.72.
Fibroblasts in cancer: Unity in heterogeneity.
Chhabra Y, Weeraratna A
Cell. 2023; 186(8):1580-1609.
PMID: 37059066
PMC: 11422789.
DOI: 10.1016/j.cell.2023.03.016.
Identification and Characterization of Metabolic Subtypes of Endometrial Cancer Using a Systems-Level Approach.
Srivastava A, Vinod P
Metabolites. 2023; 13(3).
PMID: 36984849
PMC: 10054278.
DOI: 10.3390/metabo13030409.
Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer.
Owen J, Clayton A, Pearson H
Biomolecules. 2023; 13(1).
PMID: 36671452
PMC: 9856041.
DOI: 10.3390/biom13010067.
A miniaturized screening platform to identify novel regulators of extracellular matrix alignment.
Jones C, Sharick J, Sizemore S, Cukierman E, Strohecker A, Leight J
Cancer Res Commun. 2022; 2(11):1471-1486.
PMID: 36530465
PMC: 9757767.
DOI: 10.1158/2767-9764.CRC-22-0157.
Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer.
Kim N, Kim Y, Lee K, Park E, Lee Y, Hwang S
Front Oncol. 2022; 12:942735.
PMID: 35992873
PMC: 9389008.
DOI: 10.3389/fonc.2022.942735.
Stromal p53 Regulates Breast Cancer Development, the Immune Landscape, and Survival in an Oncogene-Specific Manner.
Wu J, Liu X, Reeser J, Trimboli A, Pecot T, Sizemore G
Mol Cancer Res. 2022; 20(8):1233-1246.
PMID: 35533313
PMC: 9357052.
DOI: 10.1158/1541-7786.MCR-21-0960.
Loss of DRO1/CCDC80 in the tumor microenvironment promotes carcinogenesis.
Christian J, Pastula A, Herbst A, Neumann J, Marschall M, Ofner A
Oncotarget. 2022; 13:615-627.
PMID: 35422964
PMC: 9004603.
DOI: 10.18632/oncotarget.28084.
Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET.
Gilardi L, Airo Farulla L, Demirci E, Clerici I, Omodeo Sale E, Ceci F
Biomedicines. 2022; 10(3).
PMID: 35327325
PMC: 8945705.
DOI: 10.3390/biomedicines10030523.
Clinical and therapeutic relevance of cancer-associated fibroblasts.
Chen Y, McAndrews K, Kalluri R
Nat Rev Clin Oncol. 2021; 18(12):792-804.
PMID: 34489603
PMC: 8791784.
DOI: 10.1038/s41571-021-00546-5.
Comprehensive Study of Germline Mutations and Double-Hit Events in Esophageal Squamous Cell Cancer.
Zeng B, Huang P, Du P, Sun X, Huang X, Fang X
Front Oncol. 2021; 11:637431.
PMID: 33889545
PMC: 8056176.
DOI: 10.3389/fonc.2021.637431.
Acquired radioresistance in cancer associated fibroblasts is concomitant with enhanced antioxidant potential and DNA repair capacity.
Domogauer J, de Toledo S, Howell R, Azzam E
Cell Commun Signal. 2021; 19(1):30.
PMID: 33637118
PMC: 7912493.
DOI: 10.1186/s12964-021-00711-4.